中药活性成分调节MAPK信号通路抗食管鳞癌的研究进展

高振东; 司富春

doi:10.13422/j.cnki.syfjx.202202329

您当前的位置：

首页 >

文章列表页 >

中药活性成分调节MAPK信号通路抗食管鳞癌的研究进展

综述 | 更新时间：2023-10-13

- 中药活性成分调节MAPK信号通路抗食管鳞癌的研究进展
  增强出版
- Active Ingredients of Chinese Medicine Against Esophageal Squamous Cell Carcinoma by Regulating MAPK Signaling Pathway： A Review
- 中国实验方剂学杂志 2023年29卷第21期页码：245-254
- 作者机构：
  
  1.河南中医药大学中医学院（仲景学院），郑州 450046
  2.河南中医药大学河南省中医方证信号传导重点实验室/河南省中医方证信号传导国际联合实验室，郑州 450046
- 作者简介：
  
  高振东，在读硕士，从事肿瘤中医方证研究，E-mail：zd_gao0323@163.com；
  司富春，教授，博士生导师，从事肿瘤中医方证研究，E-mail：sifc2000@hotmail.com
- 基金信息：
  
  河南省高等学校重点科研计划项目(21A360018);河南省科技攻关项目(222102310187)
- DOI：10.13422/j.cnki.syfjx.202202329
  中图分类号： R22;R242;R2-031;R287
- 纸质出版日期：2023-11-05，
  
  网络出版日期：2022-10-09，
  
  收稿日期：2022-08-27，
- 稿件说明：
扫描看全文
高振东,司富春.中药活性成分调节MAPK信号通路抗食管鳞癌的研究进展[J].中国实验方剂学杂志,2023,29(21):245-254.

GAO Zhendong,SI Fuchun.Active Ingredients of Chinese Medicine Against Esophageal Squamous Cell Carcinoma by Regulating MAPK Signaling Pathway： A Review[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(21):245-254.
高振东,司富春.中药活性成分调节MAPK信号通路抗食管鳞癌的研究进展[J].中国实验方剂学杂志,2023,29(21):245-254. DOI： 10.13422/j.cnki.syfjx.202202329.

GAO Zhendong,SI Fuchun.Active Ingredients of Chinese Medicine Against Esophageal Squamous Cell Carcinoma by Regulating MAPK Signaling Pathway： A Review[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(21):245-254. DOI： 10.13422/j.cnki.syfjx.202202329.

摘要

食管鳞癌（ESCC）是中国最主要的食管癌组织学分型，其发病机制复杂，可能与多个基因发生突变及丝裂原活化蛋白激酶（MAPK）通路、磷脂酰肌醇3-激酶（PI3K）通路等失调有关。MAPK信号通路可以被生长因子、原癌基因、氧化应激等激活，从而参与细胞的增殖、分化、迁移、凋亡等生物学功能。越来越多的证据表明MAPK信号通路在ESCC的发生发展中起到重要的作用，有望成为ESCC治疗的有效靶点。经典的MAPK家族包括细胞外信号调节激酶1/2（ERK1/2）、c-Jun氨基末端激酶1/2/3（JNK1/2/3）、p38激酶

（p38

δ）

和细胞外信号调节激酶5（ERK5），每条通路由3种级联顺序磷酸化激活的蛋白激酶体系构成。其中ERK1/2通路的激活与ESCC的增殖、迁移、耐药及凋亡抑制有关，JNK、p38、ERK5通路似乎表现出双向调节作用，并且存在MAPK内部通路之间的信号整合。食管癌化疗药物往往不良反应较大且易产生耐药性，寻找高效、低毒的药物替代治疗成为一种新的思路。研究发现黄酮类、萜类、生物碱类、皂苷类、酚类等中药活性成分能够通过靶向MAPK通路发挥抗ESCC作用，主要体现在抑制增殖、迁移、侵袭，诱导周期阻滞，促凋亡，逆转耐药等方面。因此该文就MAPK信号通路在ESCC中的调节作用及中药活性成分调节MAPK通路抗ESCC的研究进展进行总结，以期为中药防治食管癌的机制研究和新药开发提供参考。

Abstract

Esophageal squamous cell carcinoma （ESCC）， the predominant histological strain of esophageal cancer in China， is complex in pathogenesis and may be associated with mutations in several genes and dysregulation of the mitogen-activated protein kinase （MAPK） pathway， the phosphatidylinositol 3-kinase （PI3K） pathway， etc. MAPK signaling pathway can be activated by growth factors， proto-oncogenes， and oxidative stress， thus participating in biological functions such as cell proliferation， differentiation， migration， and apoptosis. More evidence shows that the MAPK signaling pathway plays an important role in the occurrence and development of ESCC and is expected to become an effective target for the treatment of ESCC. The classical MAPK family consists of extracellular signal-regulated kinases 1/2 （ERK1/2）， c-Jun N-terminal kinases 1/2/3 （JNK1/2/3）， p38

， and extracellular signal-regulated kinase 5 （ERK5）. Each pathway consists of three cascade sequentially phosphorylated and activated protein kinase systems. The activation of the ERK1/2 pathway is related to the proliferation， migration， drug resistance， and apoptosis inhibition of ESCC. JNK， p38， and ERK5 pathways seem to show bidirectional regulation， and there is signal integration between MAPK internal pathways. Chemotherapeutic drugs for esophageal cancer often have side effects and are prone to drug resistance， so it has become a new idea to find effective and low-toxic drug alternatives. Studies have found that flavonoids， terpenoids， alkaloids， saponins， phenols， and other active ingredients in Chinese medicine can play an anti-ESCC effect by targeting the MAPK pathway， which is mainly reflected in inhibiting proliferation， migration， and invasion， inducing cycle arrest， promoting apoptosis， reversing drug resistance， etc. Therefore， this paper reviewed the regulatory role of the MAPK signaling pathway in ESCC and the research progress in active ingredients of Chinese medicine in regulating MAPK pathway against ESCC to provide references for the mechanism research and new drug development of Chinese medicine in the prevention and treatment of esophageal cancer.

关键词

食管鳞癌丝裂原活化蛋白激酶（MAPK）通路中药活性成分综述

Keywords

esophageal squamous cell carcinomamitogen-activated protein kinase（MAPK）pathwayactive ingredients of Chinese medicinereview

references

SUNG H， FERLAY J， SIEGEL R L， et al. Global Cancer Statistics 2020： GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries［J］. CA Cancer J Clin，2021，71（3）：209-249.

LIN D C，HAO J J，NAGATA Y，et al.Genomic and molecular characterization of esophageal squamous cell carcinoma［J］.Nat Genet，2014，46（5）：467-473.

GAO Y B，CHEN Z L，LI J G，et al.Genetic landscape of esophageal squamous cell carcinoma［J］.Nat Genet，2014，46（10）：1097-1102.

POWELL D W，PIERCE W M，MCLEISH K R.Defining mitogen-activated protein kinase pathways with mass spectrometry-based approaches［J］.Mass Spectrom Rev，2005，24（6）：847-864.

JOHNSON G L，LAPADAT R.Mitogen-activated protein kinase pathways mediated by ERK， JNK， and p38 protein kinases［J］.Science，2002，298（5600）：1911-1912.

MATHIEN S， TESNIÈRE C， MELOCHE S. Regulation of mitogen-activated protein kinase signaling pathways by the ubiquitin-proteasome system and its pharmacological potential［J］. Pharmacol Rev，2021，73（4）：263-296.

KONDOH K，NISHIDA E.Regulation of MAP kinases by MAP kinase phosphatases［J］.Biochim Biophys Acta，2007，1773（8）：1227-1237.

LAKE D， CORRÊA SA， MÜLLER J. Negative feedback regulation of the ERK1/2 MAPK pathway［J］. Cell Mol Life Sci，2016，73（23）：4397-4413.

STURM O E，ORTON R，GRINDLAY J，et al.The mammalian MAPK/ERK pathway exhibits properties of a negative feedback amplifier［J］.Sci Signal，2010，3（153）：ra90.

WAGNER E F，NEBREDA A R.Signal integration by JNK and p38 MAPK pathways in cancer development［J］.Nat Rev Cancer，2009，9（8）：537-549.

ZHOU J， WU Z， WONG G， et al. CDK4/6 or MAPK blockade enhances efficacy of EGFR inhibition in oesophageal squamous cell carcinoma［J］. Nat Commun，2017，doi： 10.1038/ncomms13897http://dx.doi.org/10.1038/ncomms13897.

HU X， ZHAI Y， KONG P， et al. FAT1 prevents epithelial mesenchymal transition （EMT） via MAPK/ERK signaling pathway in esophageal squamous cell cancer［J］. Cancer Lett，2017，doi： 10.1016/j.canlet.2017.03.033http://dx.doi.org/10.1016/j.canlet.2017.03.033.

ZHANG J，ZHI H，ZHOU C，et al.Up-regulation of fibronectin in oesophageal squamous cell carcinoma is associated with activation of the ERK pathway［J］.J Pathol，2005，207（4）：402-409.

CARGNELLO M， ROUX P P. Activation and function of the MAPKs and their substrates， the MAPK-activated protein kinases［J］. Microbiol Mol Biol Rev，2011，75（1）：50-83.

SHI H，JU Q，MAO Y，et al.TAK1 Phosphorylates RASSF9 and inhibits esophageal squamous tumor cell proliferation by targeting the RAS/MEK/ERK axis［J］.Adv Sci （Weinh），2021，8（5）：2001575.

FUNG T M，NG K Y，TONG M，et al.Neuropilin-2 promotes tumourigenicity and metastasis in oesophageal squamous cell carcinoma through ERK-MAPK-ETV4-MMP-E-cadherin deregulation［J］.J Pathol，2016，239（3）：309-319.

WANG Y， WANG G， MA Y， et al. FAT1， a direct transcriptional target of E2F1， suppresses cell proliferation， migration and invasion in esophageal squamous cell carcinoma［J］. Chin J Cancer Res，2019，31（4）：609-619.

GUO J C， XIE Y M， RAN L Q， et al. L1CAM drives oncogenicity in esophageal squamous cell carcinoma by stimulation of ezrin transcription［J］. J Mol Med （Berl），2017，95（12）：1355-1368.

KUMAR J D，KANDOLA S，TISZLAVICZ L，et al.The role of chemerin and ChemR23 in stimulating the invasion of squamous oesophageal cancer cells［J］.Br J Cancer，2016，114（10）：1152-1159.

GE Y， FAN X， HUANG X， et al. DCLK1-Short splice variant promotes esophageal squamous cell carcinoma progression via the MAPK/ERK/MMP2 pathway［J］. Mol Cancer Res， 2021，19（12）：1980-1991.

NG H Y， LI J， TAO L， et al. Chemotherapeutic treatments increase PD-L1 expression in esophageal squamous cell carcinoma through EGFR/ERK activation［J］. Transl Oncol， 2018，11（6）：1323-1333.

ZHANG X，LI X，LI X，et al.ANXA1 silencing increases the sensitivity of cancer cells to low-concentration arsenic trioxide treatment by inhibiting ERK MAPK activation［J］.Tumori，2015，101（4）：360-367.

GAO Y，LI W，JIA L，et al.Enhancement of （-）-epigallocatechin-3-gallate and theaflavin-3-3'-digallate induced apoptosis by ascorbic acid in human lung adenocarcinoma SPC-A-1 cells and esophageal carcinoma Eca-109 cells via MAPK pathways［J］.Biochem Biophys Res Commun，2013，438（2）：370-374.

SUGIURA R，SATOH R，TAKASAKI T. ERK： A double-edged sword in cancer. ERK-dependent apoptosis as a potential therapeutic strategy for cancer［J］.Cells，2021，10（10）：2509.

QIN X， ZHENG S， LIU T，et al. Roles of phosphorylated JNK in esophageal squamous cell carcinomas of Kazakh ethnic［J］. Mol Carcinog，2014，53（7）：526-36.

丁涛，张祥宏，李学民，等.p-JNK JNK和PPARγ在食管癌变过程中的表达及其意义［J］.中国肿瘤临床，2008，35（23）：1348-1352.

QIAO Z， CHENG Y， LIU S， et al. Casticin inhibits esophageal cancer cell proliferation and promotes apoptosis by regulating mitochondrial apoptotic and JNK signaling pathways［J］. Naunyn Schmiedebergs Arch Pharmacol， 2019，392（2）：177-187.

ZHANG Y， DU J， DUAN X， et al. RIPK1 contributes to cisplatin-induced apoptosis of esophageal squamous cell carcinoma cells via activation of JNK pathway［J］. Life Sci，2021， doi： 10.1016/j.lfs.2021.119064http://dx.doi.org/10.1016/j.lfs.2021.119064.

CHENG Y， QIAO Z， DANG C， et al. p38 predicts depression and poor outcome in esophageal cancer［J］. Oncol Lett，2017，14（6）：7241-7249.

ZHENG S T，ZHANG C S，QIN X，et al.The status of phosphorylated p38 in esophageal squamous cell carcinoma［J］.Mol Biol Rep，2012，39（5）：5315-5321.

杨晓龙，胡开锋，刘明佳，等.MKK6过表达调控SIRT1影响食管癌细胞肿瘤行为学的体外研究［J］.四川大学学报：医学版，2015，46（4）：548-553.

O'CALLAGHAN C，FANNING L J，HOUSTON A，et al.Loss of p38δ mitogen-activated protein kinase expression promotes oesophageal squamous cell carcinoma proliferation， migration and anchorage-independent growth［J］.Int J Oncol，2013，43（2）：405-415.

CHEN R S， SONG Y M， ZHOU Z Y， et al. Disruption of xCT inhibits cancer cell metastasis via the caveolin-1/beta-catenin pathway［J］. Oncogene， 2009，28（4）：599-609.

LIONI M，NOMA K，SNYDER A，et al.Bortezomib induces apoptosis in esophageal squamous cell carcinoma cells through activation of the p38 mitogen-activated protein kinase pathway［J］.Mol Cancer Ther，2008，7（9）：2866-2875.

LIU J，HAN L，LI B，et al.F-box only protein 31 （FBXO31） negatively regulates p38 mitogen-activated protein kinase （MAPK） signaling by mediating lysine 48-linked ubiquitination and degradation of mitogen-activated protein kinase kinase 6 （MKK6）［J］.J Biol Chem，2014，289（31）：21508-21518.

ZHONG D，GU C，SHI L，et al.Obatoclax induces G1/G0-phase arrest via p38/p21（waf1/Cip1） signaling pathway in human esophageal cancer cells［J］.J Cell Biochem，2014，115（9）：1624-1635.

李进科，付建军，张永国，等.ERK5在食管癌及癌旁正常组织中的表达及意义［J］.贵阳医学院学报，2015，40（9）：982-984.

GAVINE P R， WANG M， YU D， et al. Identification and validation of dysregulated MAPK7 （ERK5） as a novel oncogenic target in squamous cell lung and esophageal carcinoma［J］. BMC Cancer，2015， doi： 10.1186/s12885-015-1455-yhttp://dx.doi.org/10.1186/s12885-015-1455-y.

WANG L， XIONG X， YAO Z， et al. Chimeric RNA ASTN2-PAPPAas aggravates tumor progression and metastasis in human esophageal cancer［J］. Cancer Lett， 2021，doi： 10.1016/j.canlet.2020.10.052http://dx.doi.org/10.1016/j.canlet.2020.10.052.

宓伟，赵倩，练武，等.山楂原花青素诱导食管癌Eca109细胞凋亡的分子机制研究［J］.营养学报，2015，37（4）：389-392，398.

SUTTER A P， MAASER K， BARTHEL B， et al. Ligands of the peripheral benzodiazepine receptor induce apoptosis and cell cycle arrest in oesophageal cancer cells： Involvement of the p38 MAPK signalling pathway［J］. Br J Cancer， 2003，89（3）：564-572.

SUTTER A P， MAASER K， GERST B， et al. Enhancement of peripheral benzodiazepine receptor ligand-induced apoptosis and cell cycle arrest of esophageal cancer cells by simultaneous inhibition of MAPK/ERK kinase［J］. Biochem Pharmacol， 2004，67（9）：1701-1710.

WANG W W， ZHAO Z H， WANG L， et al. MicroRNA-134 prevents the progression of esophageal squamous cell carcinoma via the PLXNA1-mediated MAPK signalling pathway［J］. E Bio Med， 2019，doi： 10.1016/j.ebiom.2019.07.050http://dx.doi.org/10.1016/j.ebiom.2019.07.050.

BAO S， JI Z， SHI M， et al. EPB41L5 promotes EMT through the ERK/p38 MAPK signaling pathway in esophageal squamous cell carcinoma［J］. Pathol Res Pract， 2021， doi： 10.1016/j.prp.2021.153682http://dx.doi.org/10.1016/j.prp.2021.153682.

ZHU Y H，FU L，CHEN L，et al.Downregulation of the novel tumor suppressor DIRAS1 predicts poor prognosis in esophageal squamous cell carcinoma［J］.Cancer Res，2013，73（7）：2298-2309.

SHI W， SONG J， GAO Z，et al. Downregulation of miR-7-5p inhibits the tumorigenesis of esophagus cancer via targeting KLF4［J］. Onco Targets Ther，2020，doi： 10.2147/OTT.S251508http://dx.doi.org/10.2147/OTT.S251508.

LIU J， LV L， GONG J， et al. Overexpression of F-box only protein 31 predicts poor prognosis and deregulates p38α- and JNK-mediated apoptosis in esophageal squamous cell carcinoma［J］. Int J Cancer， 2018，142（1）：145-155.

CHEN H， YAO X， DI X， et al. MiR-450a-5p inhibits autophagy and enhances radiosensitivity by targeting dual-specificity phosphatase 10 in esophageal squamous cell carcinoma［J］. Cancer Lett， 2020， doi： 10.1016/j.canlet.2020.01.037http://dx.doi.org/10.1016/j.canlet.2020.01.037.

WAKITA A，MOTOYAMA S，SATO Y，et al.REG Iα activates c-Jun through MAPK pathways to enhance the radiosensitivity of squamous esophageal cancer cells［J］.Tumour Biol，2015，36（7）：5249-5254.

KWAK A W， LEE M J， LEE M H，et al. The 3-deoxysappanchalcone induces ROS-mediated apoptosis and cell cycle arrest via JNK/p38 MAPKs signaling pathway in human esophageal cancer cells［J］. Phytomedicine， 2021， doi： 10.1016/j.phymed.2021.153564http://dx.doi.org/10.1016/j.phymed.2021.153564.

KWAK A W， CHOI J S， LEE M H， et al. Retrochalcone echinatin triggers apoptosis of esophageal squamous cell carcinoma via ROS- and ER stress-mediated signaling pathways［J］. Molecules， 2019， doi： 10.3390/molecules24224055http://dx.doi.org/10.3390/molecules24224055.

KWAK AW， CHOI JS， LIU K， et al. Licochalcone C induces cell cycle G1 arrest and apoptosis in human esophageal squamous carcinoma cells by activation of the ROS/MAPK signaling pathway［J］. J Chemother， 2020，32（3）：132-143.

WANG X， ZHU Y， ZHU L， et al. Eupatilin inhibits the proliferation of human esophageal cancer TE1 cells by targeting the Akt‑GSK3β and MAPK/ERK signaling cascades［J］. Oncol Rep， 2018，39（6）：2942-2950.

QIN T， ZHAO J， LIU X， et al. Luteolin combined with low-dose paclitaxel synergistically inhibits epithelial-mesenchymal transition and induces cell apoptosis on esophageal carcinoma in vitro and in vivo［J］. Phytother Res， 2021，35（11）：6228-6240.

ZHAO S， JIANG Y， ZHAO J， et al. Quercetin-3-methyl ether inhibits esophageal carcinogenesis by targeting the Akt/mTOR/p70S6K and MAPK pathways［J］. Mol Carcinog， 2018，57（11）：1540-1552.

DING Z，LAO Y，ZHANG H，et al.Griffipavixanthone， a dimeric xanthone extracted from edible plants， inhibits tumor metastasis and proliferation via downregulation of the RAF pathway in esophageal cancer［J］.Oncotarget，2016，7（2）：1826-1837.

WANG J N， CHE Y， YUAN Z Y， et al. Acetyl-macrocalin B suppresses tumor growth in esophageal squamous cell carcinoma and exhibits synergistic anti-cancer effects with the Chk1/2 inhibitor AZD7762［J］. Toxicol Appl Pharmacol， 2019， doi： 10.1016/j.taap.2019.01.005http://dx.doi.org/10.1016/j.taap.2019.01.005.

CHE Y， WANG J， YUAN Z， et al. The therapeutic effects of Longikaurin A， a natural ent-kauranoid， in esophageal squamous cell carcinoma depend on ROS accumulation and JNK/p38 MAPK activation［J］. Toxicol Lett， 2017，doi： 10.1016/j.toxlet.2017.08.005http://dx.doi.org/10.1016/j.toxlet.2017.08.005.

JIANG S， QIU Y， WANG Z， et al. Carnosic Acid induces antiproliferation and anti-metastatic property of esophageal cancer cells via MAPK signaling pathways［J］. J Oncol， 2021， doi： 10.1155/2021/4451533http://dx.doi.org/10.1155/2021/4451533.

YANCHUN M， YI W， LU W， et al. Triptolide prevents proliferation and migration of esophageal squamous cell cancer via MAPK/ERK signaling pathway［J］. Eur J Pharmacol， 2019， doi： 10.1016/j.ejphar.2019.02.030http://dx.doi.org/10.1016/j.ejphar.2019.02.030.

李声. 西红花酸对人食管鳞癌KYSE-150细胞的抑制作用及其机制［D］.广州：中山大学，2016.

胡建莉，伍钢，肖兰.氧化苦参碱对人食管癌细胞株Eca109增殖及凋亡的影响［J］.中国医院药学杂志，2007，27（12）：1662-1665.

彭聪，黄曦文，李千，等.盐酸石蒜碱诱导人食管癌细胞Eca-109凋亡的分子机制［J］.西华师范大学学报：自然科学版，2020，41（4）：347-351.

姚雯. 血根碱抗氧化活性及其对MKN-45和TE-1癌细胞凋亡的研究［D］.咸阳：西北农林科技大学，2014.

WEN X， ZHANG X， QU S， et al. Coptisine induces G2/M arrest in esophageal cancer cell via the inhibition of p38/ERK1/2/claudin-2 signaling pathway［J］. Pharmazie， 2021，76（5）：202-207.

QIU Y， FANG B， THUY NTT， et al. Narciclasine suppresses esophageal cancer cell proliferation and migration by inhibiting the FAK signaling pathway［J］. Eur J Pharmacol， 2022， doi： 10.1016/j.ejphar.2021.174669http://dx.doi.org/10.1016/j.ejphar.2021.174669.

AN K， ZHANG Y， LIU Y， et al. Neferine induces apoptosis by modulating the ROS‑mediated JNK pathway in esophageal squamous cell carcinoma［J］. Oncol Rep， 2020，44（3）：1116-1126.

刘红岗，朱以芳，董小平，等.根皮素通过细胞外调节蛋白激酶信号通路抑制食管癌细胞系增殖的机制研究［J］.华南国防医学杂志，2017，31（3）：152-156.

XIE X， ZU X， LIU F， et al. Purpurogallin is a novel mitogen-activated protein kinase kinase 1/2 inhibitor that suppresses esophageal squamous cell carcinoma growth in vitro and in vivo［J］. Mol Carcinog， 2019，58（7）：1248-1259.

CHANG X， ZHAO J， TIAN F， et al. Aloe-emodin suppresses esophageal cancer cell TE1 proliferation by inhibiting Akt and ERK phosphorylation［J］. Oncol Lett， 2016，12（3）：2232-2238.

ZANG Y Q， ZHAI Y Q， FENG Y Y， et al. Molecular mechanisms of quinalizarin induces apoptosis and G0/G1 cell cycle of human esophageal cancer HCE-4 cells depends on MAPK， STAT3， and NF-κB signaling pathways［J］. Environ Toxicol， 2021，36（2）：276-286.

王加茹，徐宛婷，朴仙姬，等.隐丹参酮诱导人食管癌HCE-4细胞凋亡的机制［J］.肿瘤防治研究，2018，45（8）：533-539.

钟方明，吕望，方礼逵，等.重楼皂苷Ⅵ激活JNK通路诱导食管癌细胞凋亡和抑制ERK/c-Myc通路调节有氧糖酵解的研究［J］.中国肿瘤，2020，29（1）：63-69.

MA J， HU X， LIAO C， et al. Gypenoside L inhibits proliferation of liver and esophageal cancer cells by inducing senescence［J］. Molecules， 2019， doi： 10.3390/molecules24061054http://dx.doi.org/10.3390/molecules24061054.

KWAK A W，YOON G，LEE M H，et al.Picropodophyllotoxin， an epimer of podophyllotoxin， causes apoptosis of human esophageal squamous cell carcinoma cells through ROS-Mediated JNK/p38 MAPK pathways［J］.Int J Mol Sci，2020，21（13）：4640.

KWAK A W，LEE M H，YOON G，et al.Deoxypodophyllotoxin， a Lignan from anthriscus sylvestris， induces apoptosis and cell cycle arrest by inhibiting the EGFR signaling pathways in esophageal squamous cell carcinoma cells［J］.Int J Mol Sci，2020，21（18）：6854.

XU J C， ZHOU X P， WANG X A， et al. Cordycepin induces apoptosis and G2/M phase arrest through the ERK pathways in esophageal cancer cells［J］. J Cancer， 2019，10（11）：2415-2424.

XU W W，HUANG Z H，LIAO L，et al.Direct targeting of CREB1 with imperatorin inhibits TGFβ2-ERK signaling to suppress esophageal cancer metastasis［J］.Adv Sci （Weinh），2020，7（16）：2000925.

MA M， ZHANG C， XIANG XH， et al. p-Hydroxylcinnamaldehyde induces the differentiation of oesophageal carcinoma cells via the cAMP-RhoA-MAPK signalling pathway［J］. Sci Rep， 2016， doi： 10.1038/srep31315http://dx.doi.org/10.1038/srep31315.

HAN S，WANG Y，MA J，et al.Sulforaphene inhibits esophageal cancer progression via suppressing SCD and CDH3 expression， and activating the GADD45B-MAP2K3-p38-p53 feedback loop［J］.Cell Death Dis，2020，11（8）：713.

YIN X，ZHANG J，LI X，et al.DADS suppresses human esophageal xenograft tumors through RAF/MEK/ERK and mitochondria-dependent pathways［J］.Int J Mol Sci，2014，15（7）：12422-12441.

YIN X，ZHANG R，FENG C，et al.Diallyl disulfide induces G2/M arrest and promotes apoptosis through the p53/p21 and MEK-ERK pathways in human esophageal squamous cell carcinoma［J］.Oncol Rep，2014，32（4）：1748-1756.

FAN W，SUN L，ZHOU J Q，et al.Marsdenia tenacissima extract induces G0/G1 cell cycle arrest in human esophageal carcinoma cells by inhibiting mitogen-activated protein kinase （MAPK） signaling pathway［J］.Chin J Nat Med，2015，13（6）：428-437.

DUAN X， PAN L， DENG Y， et al. Dandelion root extract affects ESCC progression via regulating multiple signal pathways［J］. Food Funct， 2021，12（19）：9486-9502.

陈飞，王悠清.1990—2019年中国食管癌疾病负担及其变化趋势分析［J］.中国肿瘤，2021，30（6）：401-407.

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

中医药调控PI3K/Akt分子通路治疗慢性荨麻疹研究进展

半夏白术天麻汤治疗心脑血管疾病的研究进展

大柴胡汤在消化系统肿瘤中的研究进展

缺氧微环境对乳腺癌的影响及中药的干预作用